6th CKD Drug Development Summit: Countdown Begins

Merrimack to dissolve after recording $225M milestone; Cogent’s $225M placement

Plus, news about Larimar Therapeutics, Metagenomi, NextPoint Therapeutics, MeiraGTx, Codexis, Invitae, Immunome and BioXcel Therapeutics: Ipsen to pay $225M to Merrimack Pharmaceuticals: The milestone payout

February 15, 2024

AEVIS VICTORIA SA – Swiss Hotel Properties SA expands its real estate portfolio in Zermatt – Biotech Investments

AEVIS VICTORIA SA / Key word(s): Real Estate AEVIS VICTORIA SA – Swiss Hotel Properties SA expands its real estate portfolio in Zermatt 03.10.2023 /

October 4, 2023

Sanofi’s $17bn sale of Opella to US investors advances following government deal – Pharmaceutical Technology

Opella manufactures Doliprane, a popular painkiller in France. Image credit: Shutterstock / Marc Bruxelle. Sanofi has entered exclusive talks with US private equity company Clayton

October 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.